Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Squamous Cell Carcinoma of Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05182866
What this trial is testing

ASP-1929 Photoimmunotherapy (PIT) Study in Patients With Recurrent Head/Neck Cancer

Who this might be right for
Head and Neck CancerSquamous Cell Carcinoma of Head and Neck
Rakuten Medical, Inc. 9
Testing effectiveness (Phase 2)Looking for participantsNCT07419464
What this trial is testing

5-Fluorouracil Response and Optimization STudy (The FROST Trial)

Who this might be right for
Squamous Cell Carcinoma of Head and NeckMetastatic Squamous Cell CarcinomaRecurrent Squamous Cell Carcinoma of the Head and Neck
Washington University School of Medicine 46
Testing effectiveness (Phase 2)Looking for participantsNCT07398664
What this trial is testing

H101 Plus TACE for r/m HNSCC

Who this might be right for
Head and Neck Squamous Cell CarcinomaOncolytic VirusTACE
West China Hospital 20
Early research (Phase 1)Study completedNCT00009841
What this trial is testing

Gene Therapy in Treating Patients With Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University of Pittsburgh 13
Testing effectiveness (Phase 2)Ended earlyNCT01606566
What this trial is testing

Evaluate the Safety and Efficacy of Amphinex Induced PCI of Bleomycin for Recurrent Head and Neck Cancer.

Who this might be right for
Recurrent Head and Neck CancerCarcinoma, Squamous Cell of Head and Neck
PCI Biotech AS 26
Testing effectiveness (Phase 2)Looking for participantsNCT06869473
What this trial is testing

Cetuximab Plus Platinum and Taxane-based Chemotherapy, Followed by Avelumab and Cetuximab, as First-line Treatment for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) Patients With a PD-L1 Combined Positive Score (CPS)≥1≤19.

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)Recurrent Head and Neck CancerMetastatic Head and Neck Cancer
Gruppo Oncologico del Nord-Ovest 67
Testing effectiveness (Phase 2)Looking for participantsNCT04857164
What this trial is testing

Study of Pembrolizumab Combined with Chemotherapy in the First Line Therapy for R/M HNSCC in China

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Yuankai Shi 150
Testing effectiveness (Phase 2)UnknownNCT03356587
What this trial is testing

A Biomarker-driven, Open Label, Single Arm, Multicentre Phase II Study of Abemaciclib in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Who Failed to Platinum-based Therapy

Who this might be right for
HNSCCHead and Neck Neoplasms
Seoul National University Hospital 32
Early research (Phase 1)Study completedNCT03452332
What this trial is testing

Stereotactic Body Radiation Therapy, Tremelimumab and Durvalumab in Treating Participants With Recurrent or Metastatic Cervical, Vaginal, or Vulvar Cancers

Who this might be right for
Advanced Cervical AdenocarcinomaAdvanced Vaginal CarcinomaAdvanced Vulvar Carcinoma+33 more
M.D. Anderson Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT00003565
What this trial is testing

Docetaxel in Treating Patients With Solid Tumors

Who this might be right for
Bladder CancerBreast CancerHead and Neck Cancer+2 more
Alliance for Clinical Trials in Oncology 109
Testing effectiveness (Phase 2)Looking for participantsNCT07254585
What this trial is testing

SYS6010 Combined With Enlonstobart In Recurrent Or Metastatic Head And Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
CSPC Megalith Biopharmaceutical Co.,Ltd. 70
Testing effectiveness (Phase 2)Study completedNCT02873819
What this trial is testing

Safety and Efficacy Study of GL-0817 (With Cyclophosphamide) for the Prevention of Recurrence of Squamous Cell Carcinoma of the Oral Cavity

Who this might be right for
Squamous Cell Carcinoma of the Oral Cavity
Gliknik Inc. 80
Not applicableUnknownNCT06465030
What this trial is testing

Identification of Pattern and Factors Affecting Recurrence in Head and Neck Carcinoma

Who this might be right for
Recurrent Head and Neck Squamous Cell Carcinoma
Sohag University 35
Testing effectiveness (Phase 2)Study completedNCT00425750
What this trial is testing

Bortezomib and Docetaxel in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 25
Early research (Phase 1)Active Not RecruitingNCT05537740
What this trial is testing

A First-in-human Study to Learn How Safe the Study Drug BAY3375968, an Anti-CCR8 Antibody, is, When Given Alone or in Combination With Pembrolizumab, How it Affects the Body, How it Moves Into, Through, and Out of the Body, and to Find the Best Dose in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Bayer 129
Testing effectiveness (Phase 2)Ended earlyNCT00093652
What this trial is testing

Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer

Who this might be right for
Esophageal Cancer
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00024089
What this trial is testing

Gefitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT00807079
What this trial is testing

Carboplatin and Topotecan in Treating Patients With Relapsed or Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
ARCAGY/ GINECO GROUP 12
Testing effectiveness (Phase 2)Study completedNCT04592484
What this trial is testing

A First-in-Human Study of CDK-002 (exoSTING) in Subjects With Advanced/Metastatic, Recurrent, Injectable Solid Tumors

Who this might be right for
Advanced Solid Tumor
Codiak BioSciences 27
Large-scale testing (Phase 3)Ended earlyNCT00198328
What this trial is testing

Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head Neck Cancer
Inovio Pharmaceuticals 84
Next Page